NCT01228435 2017-12-04
IPI-504 in NSCLC Patients With ALK Translocations
Massachusetts General Hospital
Phase 2 Terminated
Clinical Trials
5 trialsNCT00096109 2017-01-16
Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00087386 2013-04-10
Tanespimycin in Treating Patients With Stage III-IV Melanoma
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00817362 2012-12-11
Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
Infinity Pharmaceuticals, Inc.
Phase 2 Terminated
NCT00627419 2012-12-10
A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma
Infinity Pharmaceuticals, Inc.
Phase 2 Terminated